Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Clinical Trial

Multicenter Study

Comparative Study

Review

Clinical Trial, Phase II

Meta-Analysis

Systematic Review

Research Support, N.I.H., Intramural

Validation Study

Research Support, U.S. Gov't, P.H.S.

Observational Study

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2017

2013

2012

2010

2009

2008

2007

2006

2005

2004

2003

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Daclizumab""[mesh_terms]

21 Results

Searching titles within these results

Daclizumab induction/tacrolimus sparing: a randomized prospective trial in renal transplantation.

Jimmy A Light, Truman M Sasaki, Reza Ghasemian, Diana Y Barhyte, Deneen L Fowlkes

Clinical transplantation 2003;16 Suppl 7():30-3

Full Text

Abstract

A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study.

R Grenda, A Watson, R Trompeter, B Tönshoff, J Jaray, M Fitzpatrick, L Murer, K Vondrak, H Maxwell, R Van Damme-Lombaerts, C Loirat, E Mor, P Cochat, D V Milford, M Brown, N J A Webb

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010;10(4):828-836

Free Full Text

Abstract

Current status of immunosuppressive agents for solid organ transplantation in children.

Anil Dhawan, Tracy Coelho, Michael Tredger

Pediatric transplantation 2012;16(2):106-22

Full Text

Abstract

Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.

Jonathan Q Tran, Ahmed A Othman, Paul Wolstencroft, Jacob Elkins

British journal of clinical pharmacology 2017;82(1):160-7

Free Full Text

Abstract

High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis.

H Nida Sen, Grace Levy-Clarke, Lisa J Faia, Zhuqing Li, Steven Yeh, Karyl S Barron, John G Ryan, Keri Hammel, Robert B Nussenblatt

American journal of ophthalmology 2009;148(5):696-703.e1

Free Full Text

Abstract

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial.

Eric M Yoshida, Paul J Marotta, Paul D Greig, Norman M Kneteman, Denis Marleau, Marcelo Cantarovich, Kevork M Peltekian, Leslie B Lilly, Charles H Scudamore, Vincent G Bain, William J Wall, Andre Roy, Robert F Balshaw, Jeffrey S T Barkun

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(9):1064-72

Free Full Text

Abstract

Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study.

Olivier Boillot, David A Mayer, Karim Boudjema, Mauro Salizzoni, Bruno Gridelli, Franco Filipponi, Pavel Trunecka, Marek Krawczyk, Pierre-Alain Clavien, Christian Ducerf, Carlos Margarit, Raimund Margreiter, José Mir Pallardo, Krister Hoeckerstedt, George-Phillipe Pageaux

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(1):61-7

Free Full Text

Abstract

Inferior late functional and metabolic outcomes in African American simultaneous kidney-pancreas recipients.

J Rogers, R J Stratta, A Lo, R R Alloway

Transplantation proceedings 2006;37(8):3552-4

Full Text

Abstract

Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation.

Gaetano Ciancio, Jeffrey J Gaynor, Junichiro Sageshima, Giselle Guerra, Alberto Zarak, David Roth, Randolph Brown, Warren Kupin, Linda Chen, Lois Hanson, Lissett Tueros, Phillip Ruiz, Alan S Livingstone, George W Burke

Transplantation 2012;92(12):1348-57

Full Text

Abstract

Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil.

K Washburn, K V Speeg, R Esterl, F Cigarroa, M Pollack, C Tourtellot, P Maxwell, G Halff

Transplantation 2001;72(10):1675-9

Full Text

Abstract

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

R Woodroffe, G L Yao, C Meads, S Bayliss, A Ready, J Raftery, R S Taylor

Health technology assessment (Winchester, England) 2007;9(21):1-179, iii-iv

Free Full Text

Abstract

Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantation.

J Rogers, R J Stratta, A Lo, R R Alloway

Transplantation proceedings 2006;37(8):3549-51

Full Text

Abstract

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.

Lionel Rostaing, Diego Cantarovich, Georges Mourad, Klemens Budde, Paolo Rigotti, Christophe Mariat, Raimund Margreiter, Luis Capdevilla, Phillippe Lang, Paul Vialtel, Joaquin Ortuño-Mirete, Bernard Charpentier, Christophe Legendre, Jaime Sanchez-Plumed, Federico Oppenheimer, Michele Kessler

Transplantation 2005;79(7):807-14

Full Text

Abstract

No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study.

Cornelis G ter Meulen, Iza van Riemsdijk, Ronald J Hené, Maarten H L Christiaans, George F Borm, Frans H M Corstens, Teun van Gelder, Luuk B Hilbrands, Willem Weimar, Andries J Hoitsma

Transplantation 2004;78(1):101-6

Full Text

Abstract

Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.

Gaetano Ciancio, George W Burke, Jeffrey J Gaynor, David Roth, Junichiro Sageshima, Warren Kupin, Lissett Tueros, Lois Hanson, Anne Rosen, Phillip Ruiz, Joshua Miller

Transplantation 2008;86(1):67-74

Full Text

Abstract

Results: 1 – 15 / 21

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Daclizumab""[mesh_terms]

Daclizumab induction/tacrolimus sparing: a randomized prospective trial in renal transplantation.

A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study.

Current status of immunosuppressive agents for solid organ transplantation in children.

Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.

High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis.

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial.

Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study.

Inferior late functional and metabolic outcomes in African American simultaneous kidney-pancreas recipients.

Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation.

Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantation.

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.

No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study.

Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.

Results for
""Daclizumab""[mesh_terms]